Evidence map›Paper›PMID 41794120›Full record

ArticleChest2026

Association of a High Cardiovascular Disease Risk OSA Phenotype With Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Jing Xu, Younghoon Kwon, Neda Esmaeili, Scott A Sands, Mohammadreza Hajipour, Daniel Vena, Susan R Heckbert, Elsayed Z Soliman, Andrew Wellman, Erin D Michos and 3 more

Abstract readMulticenter Study
In one paragraph

Article in Chest, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jing XuDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Respiratory and Critical Care Medicine, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, China.
Younghoon KwonDivision of Cardiology, Department of Medicine, University of Washington, Seattle, WA.
Neda EsmaeiliDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Scott A SandsDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Mohammadreza HajipourDivision of Experimental Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Daniel VenaDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Susan R HeckbertDepartment of Epidemiology, University of Washington, Seattle, WA.
Elsayed Z SolimanEpidemiological Cardiology Research Center, Wake Forest School of Medicine, Winston-Salem, NC.
Andrew WellmanDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Erin D MichosDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Daniel J GottliebDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Susan RedlineDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Ali AzarbarzinDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Electronic address: aazarbarzin@bwh.harvard.edu.

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Task Area A Core Study Operations.Task Area A shall encompass annual follow-up of cohort members, clinical endpoints ascertainment, study coordination activities, maintenance of the database and biosp75N92020D00001 · NHLBI · UNIVERSITY OF WASHINGTON · PI MCCLELLAND, ROBYN LEAGH · 2020 to 2025
$17.2M
Vascular Effects of Heparan Sulfate ProteoglycansP50HL056984 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TALL, ALAN RICHARD · 1997 to 2006
$13.1M
Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and SusceptibilityR01AG070867 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI PURCELL, SHAUN M, REDLINE, SUSAN S. · 2021 to 2024
$9.9M
Atrial fibrillation burden, vascular disease of the brain and cardiac MRI in MESAR01HL127659 · NHLBI · UNIVERSITY OF WASHINGTON · PI HECKBERT, SUSAN R · 2015 to 2018
$7.4M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
TO EXERCISE OPTION PERIOD ONE (1) FOR TASK AREA A - MESA CORE OPERATIONS, FIELD CENTER.75N92020D00004 · NHLBI · NORTHWESTERN UNIVERSITY · PI SIEGEL, JONATHAN H · 2020 to 2025
$4.5M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00006 · NHLBI · UNIVERSITY OF MINNESOTA · PI PANKOW, JAMES S · 2020 to 2025
$4.4M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00003 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI POST, WENDY S · 2020 to 2025
$3.8M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00007 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BERTONI, ALAIN GERALD · 2020 to 2025
$3.5M
NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR001079NCATS NIH HHS UL1 TR001420NHLBI NIH HHS 75N92020D00001NHLBI NIH HHS 75N92020D00002NHLBI NIH HHS 75N92020D00003NHLBI NIH HHS 75N92020D00004NHLBI NIH HHS 75N92020D00005NHLBI NIH HHS 75N92020D00006NHLBI NIH HHS 75N92020D00007NHLBI NIH HHS HHSN268201500003CNHLBI NIH HHS HHSN268201500003INHLBI NIH HHS N01 HC095159NHLBI NIH HHS N01 HC095160NHLBI NIH HHS N01 HC095161NHLBI NIH HHS N01 HC095162NHLBI NIH HHS N01 HC095163NHLBI NIH HHS N01 HC095164NHLBI NIH HHS N01 HC095165NHLBI NIH HHS N01 HC095166NHLBI NIH HHS N01 HC095167NHLBI NIH HHS N01 HC095168NHLBI NIH HHS N01 HC095169NHLBI NIH HHS P50 HL056984NHLBI NIH HHS R01 HL127659NHLBI NIH HHS R01 HL153874NHLBI NIH HHS R01 HL158765NHLBI NIH HHS R01 HL176714NHLBI NIH HHS R21 HL161766NHLBI NIH HHS R21 HL167126NIA NIH HHS R01 AG070867
6 · The paper itself

Abstract

backgroundOSA is associated with atrial fibrillation (AF), but this association varies by population and definitions of OSA and AF. RESEARCH QUESTION: Is high cardiovascular disease risk (High-CVD-Risk) OSA, defined by elevated hypoxic burden (HB) or heart rate response to respiratory events (ΔHR), associated with incident AF? STUDY DESIGN AND

methodsUsing data from the Multi-Ethnic Study of Atherosclerosis, HB was quantified as the cumulative area under the desaturation curve after respiratory events, and ΔHR was quantified as the increase in heart rate on event termination. Within OSA (apnea-hypopnea index [AHI] ≥15 events/h), High-CVD-Risk OSA was defined as having either a high ΔHR or high HB (both in the highest tertile), whereas individuals with OSA who did not meet these criteria were considered to have low cardiovascular disease risk (Low-CVD-Risk). Cox proportional hazards models were used to estimate the adjusted hazard ratios of incident AF for High-CVD-Risk OSA and Low-CVD-Risk OSA (vs non-OSA, defined as AHI < 15 events/h) after adjusting for confounders.

resultsA total of 1,679 participants (45.4% male) were included, with a median age of 66.0 years (interquartile range [IQR], 60.0-74.0 years), HB of 35.3%min/h (IQR, 18.0-69.2%min/h), and ΔHR of 7.7 beats/min (IQR, 5.9-9.9 beats/min). During a median follow-up of 6.7 years, AF was identified in 14.1% of the patients with High-CVD-Risk OSA (n = 687), 10.1% of the patients with Low-CVD-Risk OSA (n = 278), and 8.4% of the patients with non-OSA (n = 714). Compared with the non-OSA group, an increased hazard ratio for AF was found in the High-CVD-Risk OSA group (hazard ratio, 1.68; 95% CI, 1.17-2.41), but not in the Low-CVD-Risk OSA group (hazard ratio, 1.20; 95% CI, 0.76-1.92). The adjusted hazard ratio was similar in female and male participants (hazard ratio, 1.71 [95% CI, 1.01-2.91] vs 1.64 [95% CI, 0.99-2.72]).

interpretationOur results show that OSA-related hypoxemia or heart rate surge may be useful for predicting which patients with OSA are at increased risk of incident AF.

Indexed as

AtherosclerosisAtrial FibrillationSleep Apnea, ObstructiveAgedFemaleHeart Disease Risk FactorsHeart RateHumansHypoxiaIncidenceMaleMiddle AgedPhenotypeProportional Hazards ModelsRisk AssessmentRisk Factorsatrial fibrillationheart ratehigh riskhypoxic burdenOSA

Identifiers

PMID41794120
PMCPMC13220130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.